It has been found that lncRNA H19 and its derived miR-675 are downregulated in metastatic compared to non-metastatic prostate cancer cell lines, while H19 upregulation increased miR-675 levels and inhibits metastatic cells migration. Here, H19 is linked to prostate cancer.